Sagent Pharmaceuticals, Inc
Sagent Pharmaceuticals, Inc received $426K in federal prime contract obligations in the 12 months ending Oct 5, 2026, down 97.5% from $16.7M the year before, and $65.9M since FY2022. Its largest customer is the Department of Health and Human Services.
Contractor details
- Unique Entity ID (UEI)
- PR1HCLM3FMW7
- CAGE code
- 4RP13
- Headquarters
- Schaumburg, IL
- Business size
- Small Business
- Parent company
- Nichi-IKO Pharmaceutical Co.,ltd. (UEI YDRLCQE4AJE7)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $0 | $64.4M |
| Department of Defense | $151K | $1.2M |
| Department of Veterans Affairs | $276K | $276K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6505 | Drugs and Biologicals | $65.7M |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | $203K |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 36C77026P0086 | Department of Veterans Affairs CIPROFLOXAXIN IVPB | $276K | Aug 11, 2026 |
| SPE2D326F199K | Department of Defense 4572169674!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $24 | Jun 17, 2026 |
| SPE2D326F172C | Department of Defense 4572043667!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $96 | Jun 5, 2026 |
| SPE2D326F135B | Department of Defense 4571894571!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $48 | May 20, 2026 |
| SPE2D326F125F | Department of Defense 4571867271!METRONIDAZOLE 500 MG/100 ML 100ML | $13 | May 15, 2026 |
| SPE2D326F090J | Department of Defense 4571706829!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $24 | May 4, 2026 |
| SPE2D326F059G | Department of Defense 4571632359!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $24 | Apr 27, 2026 |
| SPE2D326F053N | Department of Defense 4571593537!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | $96 | Apr 23, 2026 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.